HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$9.31
Day range
$9.31 - $9.55
Year range
$3.32 - $16.24
Market cap
249.65M USD
Avg Volume
54.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.72M | 77.34% |
Operating expense | 23.58M | 66.30% |
Net income | -35.51M | -57.52% |
Net profit margin | -620.68 | 11.17% |
Earnings per share | -1.56 | — |
EBITDA | -18.24M | -56.29% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.78M | 25.10% |
Total assets | 25.72M | 16.96% |
Total liabilities | 51.66M | 50.54% |
Total equity | -25.94M | — |
Shares outstanding | 26.76M | — |
Price to book | -9.50 | — |
Return on assets | -155.58% | — |
Return on capital | 651.40% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -35.51M | -57.52% |
Cash from operations | -8.85M | -6.49% |
Cash from investing | -700.00K | -157.35% |
Cash from financing | 43.00K | -99.27% |
Net change in cash | -9.51M | -255.50% |
Free cash flow | -7.04M | -157.04% |
About
Founded
2009
Headquarters
Website
Employees
112